DermTech, Inc. revenue breakdown overview

DermTech, Inc. revenue for the last year amounted to 15.30 M USD, the most of which — 14.38 M USD — came from its highest performing source at the moment, DermTech Melanoma Test, the year earlier bringing 13.79 M USD. The greatest contribution to the revenue figure was made by United States — last year it brought DermTech, Inc. 15.30 M USD, and the year before that — 14.52 M USD.